142 related articles for article (PubMed ID: 11835247)
1. Recurrent mercaptopurine-induced acute pancreatitis: a rare complication of chemotherapy for acute lymphoblastic leukemia in children.
Willert JR; Dahl GV; Marina NM
Med Pediatr Oncol; 2002 Jan; 38(1):73-4. PubMed ID: 11835247
[No Abstract] [Full Text] [Related]
2. 6-Mercaptopurine-induced recurrent acute pancreatitis in children with acute lymphoblastic leukemia/lymphoma.
Halalsheh H; Bazzeh F; Alkayed K; Salami K; Madanat F
J Pediatr Hematol Oncol; 2013 Aug; 35(6):470-2. PubMed ID: 23138114
[TBL] [Abstract][Full Text] [Related]
3. Proton pump inhibitor therapy in chemotherapy-induced pancreatitis.
Fettah A; Yarali N; Bayram C; Kirsaclioglu CT; Tunc B
J Pediatr Hematol Oncol; 2014 Nov; 36(8):660-1. PubMed ID: 23652874
[No Abstract] [Full Text] [Related]
4. Maintenance Treatment With Low-Dose Mercaptopurine in Combination With Allopurinol in Children With Acute Lymphoblastic Leukemia and Mercaptopurine-Induced Pancreatitis.
Zerra P; Bergsagel J; Keller FG; Lew G; Pauly M
Pediatr Blood Cancer; 2016 Apr; 63(4):712-5. PubMed ID: 26878433
[TBL] [Abstract][Full Text] [Related]
5. 6-mercaptopurine: efficacy and bone marrow toxicity in childhood acute lymphoblastic leukemia. Association with low (thio)purine enzyme activity.
De Abreu RA; Lambooy LH; Ahment K; Brouwer C; Keizer-Garritsen JJ; Bokkerink JP; Trijbels FJ
Adv Exp Med Biol; 2000; 486():271-5. PubMed ID: 11783498
[No Abstract] [Full Text] [Related]
6. The activity of the inosine triphosphate pyrophosphatase affects toxicity of 6-mercaptopurine during maintenance therapy for acute lymphoblastic leukemia in Japanese children.
Tanaka Y; Manabe A; Nakadate H; Kondoh K; Nakamura K; Koh K; Utano T; Kikuchi A; Komiyama T
Leuk Res; 2012 May; 36(5):560-4. PubMed ID: 22200619
[TBL] [Abstract][Full Text] [Related]
7. Genetic polymorphisms of thiopurine S-methyltransferase and 6-mercaptopurine toxicity in Japanese children with acute lymphoblastic leukaemia.
Ando M; Ando Y; Hasegawa Y; Sekido Y; Shimokata K; Horibe K
Pharmacogenetics; 2001 Apr; 11(3):269-73. PubMed ID: 11337943
[No Abstract] [Full Text] [Related]
8. Severe Recurrent Nocturnal Hypoglycemia During Chemotherapy With 6-mercaptopurine in 2 Children With Acute Lymphoblastic Leukemia.
Albiroty K; Al Sabahi A
J Pediatr Hematol Oncol; 2023 Apr; 45(3):162-163. PubMed ID: 36706266
[TBL] [Abstract][Full Text] [Related]
9. Fatal hepatotoxicity associated with 6-mercaptopurine therapy.
Laidlaw ST; Reilly JT; Suvarna SK
Postgrad Med J; 1995 Oct; 71(840):639. PubMed ID: 8545299
[No Abstract] [Full Text] [Related]
10. Acquired factor V deficiency in the setting of mercaptopurine therapy for acute lymphoblastic leukemia.
Uminski K; Khalife R; Fulcher J; Duffett L; Wang TF; Tinmouth A
Ann Hematol; 2022 May; 101(5):1137-1139. PubMed ID: 34611720
[No Abstract] [Full Text] [Related]
11. Allopurinol Use During Maintenance Therapy for Acute Lymphoblastic Leukemia Avoids Mercaptopurine-related Hepatotoxicity.
Giamanco NM; Cunningham BS; Klein LS; Parekh DS; Warwick AB; Lieuw K
J Pediatr Hematol Oncol; 2016 Mar; 38(2):147-51. PubMed ID: 26808368
[TBL] [Abstract][Full Text] [Related]
12. Heritage-specific mechanisms for cancer adverse reactions: one gene does not explain the world.
Knepper TC; McLeod HL
J Clin Oncol; 2015 Apr; 33(11):1230-1. PubMed ID: 25753435
[No Abstract] [Full Text] [Related]
13. Skin Toxicity Due to Mercaptopurine in Maintenance Therapy Among Children With Acute Lymphoblastic Leukemia.
Higgerson K; Flatt T
J Pediatr Hematol Oncol; 2023 May; 45(4):e514-e517. PubMed ID: 37027323
[TBL] [Abstract][Full Text] [Related]
14. Individualized 6-mercaptopurine increments in consolidation treatment of childhood acute lymphoblastic leukemia: A NOPHO randomized controlled trial.
Tulstrup M; Frandsen TL; Abrahamsson J; Lund B; Vettenranta K; Jonsson OG; Marquart HVH; Albertsen BK; Heyman M; Schmiegelow K
Eur J Haematol; 2018 Jan; 100(1):53-60. PubMed ID: 28983968
[TBL] [Abstract][Full Text] [Related]
15. 'Acceptability' of a new oral suspension formulation of mercaptopurine in children with acute lymphoblastic leukaemia.
Mulla H; Buck H; Price L; Parry A; Bell G; Skinner R
J Oncol Pharm Pract; 2016 Jun; 22(3):387-95. PubMed ID: 25837624
[TBL] [Abstract][Full Text] [Related]
16. Isolated decrease in factor V in children treated by 6-Mercaptopurine for acute lymphoblastic Leukemia.
Filhon B; Dumesnil C; Van Dreden P; Schneider P; Vasse M; Vannier JP
Thromb Res; 2014 Nov; 134(5):1164-6. PubMed ID: 25204998
[No Abstract] [Full Text] [Related]
17. Repeat-positive SARS-CoV-2 in a child with cancer.
Radhakrishnan V; Gangopadhyay D
Pediatr Blood Cancer; 2021 Mar; 68(3):e28744. PubMed ID: 33009874
[No Abstract] [Full Text] [Related]
18. Emerging role of NUDT15 polymorphisms in 6-mercaptopurine metabolism and dose related toxicity in acute lymphoblastic leukaemia.
Singh M; Bhatia P; Khera S; Trehan A
Leuk Res; 2017 Nov; 62():17-22. PubMed ID: 28963908
[TBL] [Abstract][Full Text] [Related]
19. Successful treatment of monoclonal, aggressive Epstein-Barr virus-associated B-cell lymphoproliferative disorder in a child with acute lymphoblastic leukemia.
Perkkiö M; Riikonen P; Seuri R; Vornanen M
Med Pediatr Oncol; 1999 Jun; 32(6):447-9. PubMed ID: 10358706
[No Abstract] [Full Text] [Related]
20. Allopurinol reverses mercaptopurine-induced hypoglycemia in patients with acute lymphoblastic leukemia.
Zhang M; Bostrom B
F1000Res; 2019; 8():176. PubMed ID: 30828444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
